Vir Biotechnology Inc. logo

Vir Biotechnology Inc.

VIR | NASDAQ
Chart Builder DCF Calculator
$10.88
+$0.28 (+2.64%)
At close: Sep 21, 2026, 4:00 PM ET
$11.31
+$0.43 (+3.95%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$1.79B
Enterprise Value
$1.4B
Beta
1.63
Average Volume
1.83M
Shares Outstanding (Diluted)
168.88M
Shares Change YoY
21.98%
Institutional Ownership
94.68%
Exchange
NASDAQ
ISIN
US92764N1028

Price Performance

Price Change 1M
11.7%
Price Change 3M
7.1%
Price Change 6M
21.0%
Price Change YTD
83.2%
Price Change 1Y
106.5%
Price Change 3Y
16.4%
Price Change 5Y
-75.2%
1M CAGR (ann.)
20.9%
1Y CAGR (ann.)
120.8%
5Y CAGR (ann.)
-27.2%
All-Time CAGR
-4.0%

Valuation

PE Ratio
-5.85
Forward PE
N/A
PEG Ratio
-0.08
Forward PEG
-0.13
PS Ratio
6.05
Forward PS
24.90
PB Ratio
1.87
P/FCF Ratio
-5.53
P/Adj. FCF Ratio
-4.85
P/OCF Ratio
-5.44
EV/Sales
4.62
EV/EBIT
-5.47
EV/EBITDA
-5.73
EV/FCF
-4.22
Earnings Yield
-17.1%
FCF Yield
-18.1%
Adj. FCF Yield
-20.6%

Financial Health

Net Cash
$528.59M
Total Debt
$93.27M
Cash & Short-Term Investments
$528.59M
Total Assets
$1.21B
Current Ratio
6.04
Quick Ratio
6.04
Debt / Equity Ratio
0.09
Debt / EBITDA
-0.38
Debt / FCF
-0.28
OCF / Debt
-3.59
Interest Coverage
0.00
Altman Z-Score
3.21
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
170.0%
Operating Profit Margin
-89.0%
EBITDA Margin
-80.6%
Net Profit Margin
-83.0%
FCF Margin
-109.3%
Adj. FCF Margin
-124.8%
SBC / Revenue
15.5%
SBC Impact (per share)
-14.2%

Returns

Return on Assets
-20.7%
Return on Equity
-30.0%
Return on Invested Capital
-23.9%
Return on Capital Employed
-24.1%
Return on Tangible Assets
-21.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
-14.8%
Revenue CAGR 5Y
11.2%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
27.3%
EPS CAGR 5Y
-320.1%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
15.2%
FCF CAGR 5Y
-553.6%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
12
EPS Growth Next 3Y
3.1%
Revenue Growth Next 3Y
-11.9%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
-$0.74
EPS Growth Est (next Q)
-36.8%
Revenue Est (next Q)
$865.13K
Revenue Growth Est (next Q)
260.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$25
Price Target Upside
129.8%

Cash Flow

Operating Cash Flow
$-334.89M
Free Cash Flow
$-331.54M
Adj. Free Cash Flow
$-378.58M
FCF Per Share
-$1.98
OCF Per Share
-$2
OCF/S Ratio
-110.4%

Income Statement

Revenue
$303.23M
Gross Profit
$515.53M
Operating Income
$-269.77M
EBITDA
$-244.41M
Net Income
$-251.68M
EPS (Diluted)
-$1.86
Revenue / Employee
$826.23K
Profit / Employee
$-685.77K
Employees
367

© 2026 bestshares.com. All rights reserved.